Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_assertion type Assertion NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_head.
- NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_assertion description "[Moreover, sema3a binding inhibition or podocyte-specific plexinA1 deletion markedly ameliorates albuminuria and abrogates renal insufficiency and the diabetic nodular glomerulosclerosis phenotype of diabetic Sema3a(+) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_provenance.
- NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_assertion evidence source_evidence_literature NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_provenance.
- NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_assertion SIO_000772 25475434 NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_provenance.
- NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_assertion wasDerivedFrom befree-2016 NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_provenance.
- NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_assertion wasGeneratedBy ECO_0000203 NP1244856.RAicvD_aJRXfxPo2Ao-BjbIgAYI48svWY25awOyy28vv8130_provenance.